文献速递真菌感染医院感染防控

含葡萄糖液体导致血清半乳甘露聚糖假阳性:病例对照研究与中断时间序列分析

Dextrose-containing fluids causing false-positive serum galactomannan: a case-control study and interrupted time series analysis.
PubMed 文献 · Clin Microbiol Infect · 2024-02-01

本研究旨在查明本中心血清曲霉抗原半乳甘露聚糖(GM)假阳性的原因。病例对照研究显示,检测前6天内输注含葡萄糖液体是GM假阳性的独立预测因素(aOR 18.60,95%CI 8.95-38.66),部分含葡萄糖液体样本GM检测呈阳性,追溯发现其糖化过程使用源自黑曲霉的酶。干预限制含葡萄糖液体使用后,中断时间序列分析显示GM假阳性率立即下降(每周-6.5%,p=0.045)并呈下降趋势(每周-0.33%,p=0.005)。

要点

  • 检测前6天内输注含葡萄糖液体是血清GM假阳性的独立预测因素(aOR 18.60)。
  • 部分含葡萄糖液体样本GM检测阳性,生产糖化过程使用黑曲霉来源酶。
  • 限制含葡萄糖液体使用后GM假阳性率立即下降并呈持续下降趋势。

核心结论

  • 输注含葡萄糖液体是导致血清曲霉抗原GM检测假阳性的主要因素。
  • 本研究促使含葡萄糖液体的生产工艺得到改进。

研究设计与样本

  • 病例对照研究,纳入568例受检患者,其中GM阳性130例,假阳性97例为病例,真阴性427例为对照。
  • 采用多变量回归分析评估假阳性GM的独立危险因素。
  • 采用中断时间序列分析评估去除已识别因素后的干预效果。

主要发现

  • 568例受检患者中GM阳性130例,其中假阳性97例。
  • 检测前6天内输注含葡萄糖液体是GM假阳性的独立预测因素(aOR 18.60,95%CI 8.95-38.66)。
  • 含葡萄糖液体样本GM检测阳性率:生产商A为34.8%(8/23),生产商B为33.3%(5/15)。
  • 生产工艺调查发现糖化过程使用源自黑曲霉的酶。
  • 干预后中断时间序列分析显示GM假阳性率立即下降(每周-6.5%,p=0.045)并呈下降趋势(每周-0.33%,p=0.005)。

临床怎么用

  • 作者发现输注含葡萄糖液体是GM假阳性的主要因素后,限制了含葡萄糖液体的使用。
  • 作者的研究促使含葡萄糖液体的生产工艺得到改进。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to identify the cause of false-positive serum Aspergillus antigen galactomannan (GM) results in our centre. METHODS: We performed a case-control study aiming to elucidate the factors associated with false-positive GM results. Independent risk factors for false-positive GM were evaluated through a multivariable regression analysis. An interrupted time series analysis was used to evaluate the effectiveness of an intervention removing the identified factors. RESULTS: Among 568 patients tested, GM was positive in 130 patients of whom 97 had false-positive GM (cases). These were compared with 427 patients with true-negative GM (controls). Administration of dextrose-containing fluids within 6 days before GM testing was an independent predictor for false-positive GM results (adjusted odds ratio [aOR], 18.60; 95% CI, 8.95-38.66. An analysis of GM presence in different dextrose-containing fluids revealed positivity in 34.8% (8 of 23) (manufacturer A) and 33.3% (5 of 15) (manufacturer B) of the samples. Investigation of the manufacturing process revealed that the saccharification process employed enzymes derived from Aspergillus niger. After identifying the root cause of false positivity, GM-containing dextrose fluid use was restricted. Interrupted time series analysis showed an immediate reduction of GM false-positivity (-6.5% per week, p = 0.045) and a declining trend (-0.33% per week, p = 0.005) postintervention. CONCLUSIONS: Administering dextrose-containing fluids was the primary factor causing false-positive serum Aspergillus antigen GM assay results. Our investigation led to a modification of the manufacturing process of the dextrose-containing fluids.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Lee R, Yoo IY, Oh EJ, et al. Dextrose-containing fluids causing false-positive serum galactomannan: a case-control study and interrupted time series analysis. Clin Microbiol Infect. 2024. PMID: 38309324. doi:10.1016/j.cmi.2024.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。